These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1636476)

  • 21. Evaluation of biochemical validation measures in determination of smoking status.
    Stookey GK; Katz BP; Olson BL; Drook CA; Cohen SJ
    J Dent Res; 1987 Oct; 66(10):1597-601. PubMed ID: 3305621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salivary cotinine levels and involuntary tobacco smoke exposure in children and adults in New Mexico.
    Coultas DB; Howard CA; Peake GT; Skipper BJ; Samet JM
    Am Rev Respir Dis; 1987 Aug; 136(2):305-9. PubMed ID: 3619189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cigarette smoking on salivary epidermal growth factor (EGF) and EGF receptor in human buccal mucosa.
    Wang SL; Milles M; Wu-Wang CY; Mardirossian G; Leung C; Slomiany A; Slomiany BL
    Toxicology; 1992 Nov; 75(2):145-57. PubMed ID: 1462352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Self-Reporting of Smoking Cessation in Cardiac Patients: How Reliable Is It and Is Reliability Associated With Patient Characteristics?
    Gerritsen M; Berndt N; Lechner L; de Vries H; Mudde A; Bolman C
    J Addict Med; 2015; 9(4):308-16. PubMed ID: 26083956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation of serum and urine cotinine in passive and active smokers and applicability in preconceptional smoking cessation counseling.
    de Weerd S; Thomas CM; Kuster JE; Cikot RJ; Steegers EA
    Environ Res; 2002 Oct; 90(2):119-24. PubMed ID: 12483802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements.
    Twardella D; Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
    Eur Heart J; 2004 Dec; 25(23):2101-8. PubMed ID: 15571825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of a saliva cotinine cut-off to distinguish pregnant smokers from pregnant non-smokers.
    Hegaard HK; Kjaergaard H; Møller LF; Wachmann H; Ottesen B
    Acta Obstet Gynecol Scand; 2007; 86(4):401-6. PubMed ID: 17486459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between self-reported smoking status and serum cotinine during pregnancy.
    McDonald SD; Perkins SL; Walker MC
    Addict Behav; 2005 May; 30(4):853-7. PubMed ID: 15833588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers.
    Curvall M; Elwin CE; Kazemi-Vala E; Warholm C; Enzell CR
    Eur J Clin Pharmacol; 1990; 38(3):281-7. PubMed ID: 2340848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relations of cotinine and carbon monoxide to self-reported smoking in a cohort of smokers and ex-smokers followed over 5 years.
    Murray RP; Connett JE; Istvan JA; Nides MA; Rempel-Rossum S
    Nicotine Tob Res; 2002 Aug; 4(3):287-94. PubMed ID: 12215237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application.
    Levi M; Dempsey DA; Benowitz NL; Sheiner LB
    J Pharmacokinet Pharmacodyn; 2007 Feb; 34(1):23-34. PubMed ID: 17206525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of Cotinine Cutoff Values for Smoking Status Classification.
    Kim S
    Int J Environ Res Public Health; 2016 Dec; 13(12):. PubMed ID: 27983665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verification of smoking status by thiocyanate in unrefrigerated, mailed saliva samples.
    Sexton M; Nowicki P; Hebel JR
    Prev Med; 1986 Jan; 15(1):28-34. PubMed ID: 3714657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of salivary concentrations of the newer antiepileptic drugs in the postal system.
    Jones MD; Ryan M; Miles MV; Tang PH; Fakhoury TA; Degrauw TJ; Baumann RJ
    Ther Drug Monit; 2005 Oct; 27(5):576-9. PubMed ID: 16175129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulated and non-stimulated saliva as biological material in the assessment of cotinine concentration.
    Bachaneki T; Nakonieczna-Rudnicka M; Piekarczyk W
    Przegl Lek; 2015; 72(10):493-5. PubMed ID: 26946552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers.
    Rubinstein ML; Thompson PJ; Benowitz NL; Shiffman S; Moscicki AB
    Nicotine Tob Res; 2007 Jan; 9(1):129-35. PubMed ID: 17365743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of urine cotinine to validate smoking self-reports in U.S. Navy recruits.
    Pokorski TL; Chen WW; Bertholf RL
    Addict Behav; 1994; 19(4):451-4. PubMed ID: 7992679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simulation and evaluation of nicotine intake during passive smoking: cotinine measurements in body fluids of nonsmokers given intravenous infusions of nicotine.
    Curvall M; Vala EK; Enzell CR; Wahren J
    Clin Pharmacol Ther; 1990 Jan; 47(1):42-9. PubMed ID: 2295218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restrictive workplace smoking policies: impact on nonsmokers' tobacco exposure.
    Marcus BH; Emmons KM; Abrams DB; Marshall RJ; Kane M; Novotny TE; Etzel RA
    J Public Health Policy; 1992; 13(1):42-51. PubMed ID: 1629358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women.
    Kim I; Wtsadik A; Choo RE; Jones HE; Huestis MA
    J Anal Toxicol; 2005 Oct; 29(7):689-95. PubMed ID: 16419402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.